ABSORB Clinical Investigation, Cohort A (ABSORB A) Everolimus Eluting Coronary Stent System Clinical Investigation

This study has been completed.
Information provided by (Responsible Party):
Abbott Vascular
ClinicalTrials.gov Identifier:
First received: March 7, 2006
Last updated: September 9, 2011
Last verified: September 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)
Patrick W Serruys, John A Ormiston, Yoshinobu Onuma, Evelyn Regar, Nieves Gonzalo, Hector M Garcia-Garcia, Koen Nieman, Nico Bruining, Cecile Dorange, Karine Miquel-Hebert, Susan Veldhof, Mark Webster, Leif Thuesen, Dariusz Dudek, A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods, The Lancet, Volume 373, Issue 9667, 14 March 2009-20 March 2009, Pages 897-910, ISSN 0140-6736
Ormiston,John A. and Patrick W.S. Serruys. Bioabsorbable Coronary Stents. Circ Cardiovasc Intervent 2009;2;255-260
Onuma, Yshinobu MD., et.al. Everolimus-eluting bioabsorbable stent-Abbott Vascular programme. EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F98-F102.
Oberhauser, James, PhD., et.al. Design Principles and Performance of Bioresorbable Polymeric Vascular Scaffolds. EuroIntervention Supplement (2009) Vol. 5 (Supplement F) F15-F22.

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):